Neuroprotection In Chronic Brain Ischemia: Clinical And Immunological Features

Yakutkhon Madjidova, Durdona Usmanova


The influence of neuroprotectorcortexin with significant immunomodulating, anti-inflammatory, neurotrophic, and neuroprotective effects on subjective and neurological symptoms, as well as immunological parameters (IL-1β,TNF-a) in chronic brain ischemia is shown in the article.


Chronic Brain Ischemia, Proinflammatory Cytokines, Myelin Basic Protein, Antibody

Full Text:



Gerasimova, M.M., Jdanov, G.N., 2001.“Autoimmune processin ischemic stroke”, Materials of VIII All-Russia Congress of neurologists, Kazan (Russia), in Russian, pp.219.

Gusev,Ye.I.,Skvortsova, V.I., 2001. “Brain ischemia”, Moscow: Medicine, in Russian, 328 p.

Dyakonov, M.M., 2002. “Large opportunities of cortexin incerebro-vascular pathology”, Moscow: Medline express, Vol. 12 (156), in Russian, pp. 9-10.

Levin, O.S., Sagova, M.M., 2004. “Influence of cortexinon neuropsychological and motor disorders in discirculatory encephalopathy (randomized double blind placebo-controlled study)”, Terra Medica Nova, No.1, in Russian, pp. 15-18.

Skvortsova, V.I., Sherstnyov, V.V., Konstantinova, N.A., et al., 2005. “Participation of autoimmune mechanisms in the development of brain ischemic damage”, J.Neurol.&Psychiatry,Vol.105, No.8, in Russian, pp. 36-40.

Skoromets, A.A., Dyakonov, M.M.,2004. “I.P. Pavlov, brain... and cortexin”, Vestn.Russ. Mill.Med.Academ., No.2 (12), pp. 29-30.



  • There are currently no refbacks.

Print ISSN 1804-5804, Online ISSN 1804-9702

(c) 2018 CBU,o.p.s.